Hydroxychloroquine authorized in the U.S.
Watch the latest video at foxnews.com
Watch the latest video at foxnews.com
@jpkiekens @cov19treatments Early treatment iniative!! Front line doctors accross the borders treat and speak ! After 1 YEAR of successful protocol, Dr Theresa Tam, stop the bias and let doctors save lives!! https://youtu.be/QciiFYJJiJk
Brazil's largest paper, @Folha, reports that Brazilians who reside in Europe are being targeted with bigotry, discrimination and verbal attacks due to the constant media reference to the "Brazilian variant," leading people to view Brazilians as threats:
https://www1.folha.uol.com.br/mundo/2021/04/brasileiros-sao-alvo-de-discriminacao-na-europa-devido-a-variante-do-virus.shtml
Greetings and welcome. COVEXIT.com offers you independent global news and policy analysis regarding COVID-19, with emphasis on early treatments. You can choose from … a) the latest noteworthy articles b) our latest video interviews with leading experts c) our landmark webinars. Also, please subscribe below to our newsletter, so you receive updates about our coverage. Thanks!
We now have a group on Telegram — https://t.me/covexitgroup
Join us also on ClubHouse! — (iPhone only)
https://www.joinclubhouse.com/club/covid-outpatient-care
RECOMMENDED/RECOMMANDÉS:
Webinar with Dr Brian Tyson and Dr George Fareed – Part 1
A Protocol for the Prevention and Early Treatment of COVID-19 in Nursing Homes
Un protocole pour la prévention et le traitement précoce du C19 dans les résidences pour aînés
Webinar with Professor Paul Marik: the Prevention & Outpatient Treatment of C19
Prophylaxie et Traitement Précoce du C19 – un Webinaire avec le Professeur de Médecine Paul Marik
Bonjour et bienvenue à COVEXIT.com, un site Web proposant des nouvelles mondiales indépendantes et une analyse des stratégies gouvernementales concernant le COVID-19, avec un accent particulier sur les traitements thérapeutiques précoces.
Par où commencer votre visite? Vous pouvez choisir parmi… a) les dernières nouvelles b) nos entrevues et webinaires.
Et abonnez vous à notre newsletter, afin de recevoir des mises à jour. Merci!